Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya

BMC Nephrology

Maarten W Taal¹  Christopher W McIntyre¹  Wiam A Alashek¹ 

[1] Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3NE, UK

关键词: Prevalence;    Libya;    Incidence;    ESKD;    Epidemiology;    Dialysis;   

Others  :  1083180
DOI  :  10.1186/1471-2369-13-33

 received in 2011-12-15, accepted in 2012-06-08,  发布年份 2012

【 摘 要 】

Background

The extent and the distribution of end stage kidney disease (ESKD) in Libya have not been reported despite provision of dialysis over 4 decades. This study aimed to develop the first comprehensive description of the epidemiology of dialysis-treated ESKD in Libya.

Methods

Structured demographic and clinical data were obtained regarding all adult patients treated at all maintenance dialysis facilities (n=39) in Libya from May to September 2009. Subsequently data were collected prospectively on all new patients who started dialysis from September 2009 to August 2010. Population estimates were obtained from the Libyan national statistics department. The age and gender breakdown of the population in each region was obtained from mid-2009 population estimates based on 2006 census data.

Results

The prevalence of dialysis-treated ESKD was 624 per million population (pmp). 85% of prevalent patients were aged <65 years and 58% were male. The prevalence of ESKD varied considerably with age with a peak at 55–64 years (2475 pmp for males; 2197 pmp for females). The annual incidence rate was 282 pmp with some regional variation and a substantially higher rate in the South (617 pmp). The most common cause of ESKD among prevalent and incident patients was diabetes. Other important causes were glomerulonephritis, hypertensive nephropathy and congenital or hereditary diseases.

Conclusions

Libya has a relatively high prevalence and incidence of dialysis-treated ESKD. As the country prepares to redevelop its healthcare system it is hoped that these data will guide strategies for the prevention of CKD and planning for the provision of renal replacement therapy.

【 授权许可】

   
2012 Alashek et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Rao GM: Diabetes mellitus in Libya: a retrospective study. Indian J Med Sci 1992, 46(6):174-181.
• [2]The National Board for Scientific Research T-L: Risk factors for hypertension. 2001, 32-39.
• [3]Roaeid RB, Kablan AA: Diabetes mortality and causes of death in Benghazi: a 5-year retrospective analysis of death certificates. East Mediterr Health J 2010, 16(1):65-69.
• [4]Kadiki OA, Roaeid RB: Prevalence of diabetes mellitus and impaired glucose tolerance in Benghazi Libya. Diabetes Metab 2001, 27(6):647-654.
• [5]WHO: Eastern Mediterranean Regional Health Systems Observatory-Health Systems Profile- Libya. , WHO; 2007. [http://www.emro.who.int. webcite]Accessed December 2011
• [6]Salam AA, Alshekteria AA, Abd Alhadi H, Ahmed M, Mohammed A: Patient satisfaction with quality of primary health care in Benghazi, Libya. Libyan J Med 2010, 5:.
• [7]Alashek WA, McIntyre CW, Taal MW: Provision and quality of dialysis services in Libya. Hemodial Int 2011, 15(4):444-452.
• [8]Usta A, Shawish T, Mishra A, Ehtuish EF, Ajaj H, Milud N, Shebani A, Abdulmola T, Tejori U: Living related kidney transplantation in Libya: a single center experience. Transplant Proc 2008, 40(10):3428-3433.
• [9]Ehtuish EF, Abouna GM, Shebani AH, Abdulmola TS, Shawesh TZ: Kidney transplantation in Libya: a North African and Middle Eastern perspective. Exp Clin Transplant 2006, 4(1):425-428.
• [10]Abboud O: Incidence, prevalence, and treatment of end-stage renal disease in the Middle East. Ethn Dis 2006, 16(2 Suppl 2):S2-2-4.
• [11]Najafi I: Peritoneal dialysis in iran and the middle East. Perit Dial Int 2009, 29(Suppl 2):S217-S221.
• [12]Saudi Centre for Organ Transplantation Annual Report 2009 2009. [http://www.scot.org.sa/Accessed webcite]December 2011
• [13]El Minshawy O: End-stage renal disease in the El-Minia Governorate, upper Egypt: an epidemiological study. Saudi J Kidney Dis Transpl 2011, 22(5):1048-1054.
• [14]Alashek W, Ehtuish E, Elhabashi A, Emberish W, Mishra A: Reasons for unwillingness of libyans to donate organs after death. Libyan J Med 2009, 4(3):110-113.
• [15]ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2007. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands; 2009. [http://www.era-edta-reg.org/ webcite]Accessed December 2011
• [16]Shigidi MM, Ramachandiran G, Rashed AH, Fituri OM: Demographic data and hemodialysis population dynamics in Qatar: a five year survey. Saudi J Kidney Dis Transpl 2009, 20(3):493-500.
• [17]Counil E, Cherni N, Kharrat M, Achour A, Trimech H: Trends of incident dialysis patients in Tunisia between 1992 and 2001. Am J Kidney Dis 2008, 51(3):463-470.
• [18]Prabahar MR, Chandrasekaran V, Soundararajan P: Epidemic of chronic kidney disease in India -what can be done? Saudi J Kidney Dis Transpl 2008, 19(5):847-853.
• [19]Ngo LYOL, Guat LD: 16th Report of the Malaysian Dialysis and Transplant Registry 2008. 2008. [http://www.msn.org.my/ webcite]Accessed December 2011
• [20]Batieha A, Abdallah S, Maghaireh M, Awad Z, Al-Akash N, Batieneh A, Ajlouni KA: Epidemiology and cost of haemodialysis in Jordan. East Mediterr Health J 2007, 13(3):654-663.
• [21]Moukeh G, Yacoub R, Fahdi F, Rastam S, Albitar S: Epidemiology of hemodialysis patients in Aleppo city. Saudi J Kidney Dis Transpl 2009, 20(1):140-146.
• [22]Mathur AK, Ashby VB, Sands RL, Wolfe RA: Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant 2010, 10(4 Pt 2):1069-1080.
• [23]Wimmer F, Oberaigner W, Kramar R, Mayer G: Regional variability in the incidence of end-stage renal disease: an epidemiological approach. Nephrol Dial Transplant 2003, 18(8):1562-1567.
• [24]Steenkamp R, Castledine C, Feest T, Fogarty D: UK Renal Registry 13th Annual Report (December 2010): chapter 2: UK RRT Prevalence in 2009: national and centre-specific analyses. In . UK Renal Registry, Bristol; 2010:35-60.
• [25]Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, et al.: United States renal data system 2008 annual data report. Am J Kidney Dis 2009, 53(1 Suppl):S1-S374.
• [26]Gilg J, Castledine C, Fogarty D, Feest T: UK Renal Registry 13th Annual Report (December 2010): chapter 1: UK RRT Incidence in 2009: national and centre-specific analyses. In . UK Renal Registry, ; 2010:9-33.
• [27]Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW: Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 2004, 44(5 Suppl 2):16-21.
• [28]Iseki K, Nakai S, Shinzato T, Nagura Y, Akiba T: Increasing gender difference in the incidence of chronic dialysis therapy in Japan. Ther Apher Dial 2005, 9(5):407-411.
• [29]Atkins RC: The epidemiology of chronic kidney disease. Kidney Int Suppl 2005, 94:S14-S18.
• [30]Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
• [31]Belqacem S: Health issues in the Arab American community. Commentary: the growing risk factors for noncommunicable diseases in the Arab world. Ethn Dis 2007, 17(2 Suppl 3):S3-51-S53-52.
• [32]Khogali M: Health and disease in a changing Arab world 2000/2025/2050: global, environmental, and climate change and emerging diseases. Ethn Dis 2005, 15(1 Suppl 1):S1-74-75.
• [33]Iseki K: Factors influencing the development of end-stage renal disease. Clin Exp Nephrol 2005, 9(1):5-14.
• [34]Farag Y, Al Wakeel J: Diabetic Nephropathy in the Arab Gulf Countries. Nephron Clin Pract 2011, 119(4):c317-c323.
• [35]Kramer H: Screening for kidney disease in adults with diabetes and prediabetes. Curr Opin Nephrol Hypertens 2005, 14(3):249-252.
• [36]Zhang AH, Zhong H, Tang W, Chen SY, He L, Wang S, Su CY, Lu XH, Wang T: Establishing a renal management clinic in China: initiative, challenges, and opportunities. Int Urol Nephrol 2008, 40(4):1053-1058.
• [37]El-Reshaid W, El-Reshaid K, Kapoor M, Hakim A: Chronic renal disease in Kuwaiti nationals: a prospective study during the past 4 years. Ren Fail 2005, 27(2):227-233.
• [38]Cerdas M: Chronic kidney disease in Costa Rica. Kidney Int Suppl 2005, 97:S31-S33.
• [39]Badheeb AM: Causes of chronic renal failure in hemodialysis unit: a single center experience in Yemen. Saudi J Kidney Dis Transpl 2006, 17(1):66-69.
• [40]Gooneratne IK, Ranaweera AK, Liyanarachchi NP, Gunawardane N, Lanerolle RD: Epidemiology of chronic kidney disease in a Sri Lankan population. Int J Diabetes Dev Ctries 2008, 28(2):60-64.
• [41]Rizvi SA, Manzoor K: Causes of chronic renal failure in pakistan: a single large center experience. Saudi J Kidney Dis Transpl 2002, 13(3):376-379.
• [42]Teebi AS, Teebi SA, Porter CJ, Cuticchia AJ: Arab genetic disease database (AGDDB): a population-specific clinical and mutation database. Hum Mutat 2002, 19(6):615-621.
• [43]Barbari A, Stephan A, Masri M, Karam A, Aoun S, El Nahas J, Bou Khalil J: Consanguinity-associated kidney diseases in Lebanon: an epidemiological study. Mol Immunol 2003, 39(17–18):1109-1114.
• [44]Hoodfar E, Teebi AS: Genetic referrals of Middle Eastern origin in a western city: inbreeding and disease profile. J Med Genet 1996, 33(3):212-215.